×
0 0 0 0 0 0 0 0
Stockreport

What to Expect From Celldex Therapeutics, Inc. in 2018 [The Motley Fool]

CELLDEX THERAPEUTICS (CLDX)  More Company Research Source: The Motley Fool
Last celldex therapeutics earnings: 5/10 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
PDF After a decades-long journey, 2018 could be the year Celldex Therapeutics transitions from a clinical-stage biotech to one with a product to sell. Celldex Therapeutics, Inc. ( NASDAQ:CLDX ) entered 2018 with its lead drug in a fully enrolled pivotal trial. The situation echoes the clinical-stage biotech's position at the beginning of 2016; later, an unexpected failure left investors scarred .  This year should be much different. The one we've all been waiting for Finding 327 advanced-stage, triple-negative breast cancer patients with tumors that express high levels of a specific surface protein that glembatumumab vedotin (glemba) targets wasn't easy, but Celldex finally got it done. Investigators randomized the last patients into groups receiving the company's lead candidate or standard chemotherapy last August, but won't let anyone know which group they're in until 203 patients show signs of disease progression. Image source: Getty Images. In early 2016, [Read more]

IMPACT SNAPSHOT EVENT TIME: CLDX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS